The Arthroscopic Visualization Instrument market demonstrates strong market attractiveness, driven by rising orthopedic procedure volumes, technological advancements, and an aging population with musculoskeletal disorders. The market is projected to grow at a CAGR of 6.5โ7.2% through 2030, with minimally invasive surgeries and sports medicine demand acting as key tailwinds. Competitive intensity remains moderate to high, with established players like Stryker, Arthrex, and Medtronic dominating, while emerging firms leverage cost-effective solutions to gain traction. The long-term outlook is optimistic, underpinned by digitalization trends, AI integration, and expanding applications in ambulatory surgery centers. The innovation landscape is dynamic, focusing on 4K/HD imaging, ergonomic designs, and augmented reality tools to enhance surgical precision. Demandโsupply balance remains stable, though regional disparities persist due to infrastructure gaps and regulatory disparities. Key risk factors include stringent FDA/EU MDR regulations, patent litigation risks, and potential supply chain disruptions from geopolitical tensions. Strategic partnerships and R&D investments will be critical for sustaining growth in this evolving Arthroscopic Visualization Instrument market outlook.